Synopsis
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anodynin
2. Phenazone
3. Pyramidone
1. Phenazone
2. 60-80-0
3. Phenazon
4. Antipyrin
5. Analgesine
6. Anodynine
7. Anodynin
8. Azophen
9. Fenazone
10. 2,3-dimethyl-1-phenyl-5-pyrazolone
11. Antipirin
12. Antipyrinum
13. Phenozone
14. Apirelina
15. Azophene
16. Methozin
17. Parodyne
18. Phenazonum
19. Phenylone
20. Pyrazophyl
21. Sedatine
22. Sedatin
23. Dimethyloxychinizin
24. Dimethyloxyquinazine
25. Oxydimethylquinazine
26. Azophenum
27. Phenylon
28. 3-antipyrine
29. Fenazon [czech]
30. Fenazona
31. 3h-pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-2-phenyl-
32. Fenazona [inn-spanish]
33. Phenazone (pharmaceutical)
34. Fenazon
35. 1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
36. Oxydimethylquinizine
37. 1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one
38. 2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
39. 1-phenyl-2,3-dimethyl-5-pyrazolone
40. 1-phenyl-2,3-dimethylpyrazole-5-one
41. Chebi:31225
42. Nsc 7945
43. Phenazone;phenazon
44. 1,5-dimethyl-2-phenylpyrazol-3-one
45. Phenazone [inn]
46. T3cha1b51h
47. Phenazone (inn)
48. Nsc-7945
49. 1,5-dimethyl-2-phenyl-2,3-dihydro-1h-pyrazol-3-one
50. Cas-60-80-0
51. Ncgc00016274-04
52. Dsstox_cid_1117
53. Dsstox_rid_75949
54. Dsstox_gsid_21117
55. Antipyrine [jan]
56. Phenazonum [inn-latin]
57. Smr000238140
58. Ccris 1369
59. Antipyrine [usp:jan]
60. Sr-05000001566
61. Einecs 200-486-6
62. Unii-t3cha1b51h
63. Antipyrien
64. 1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one; Phenazone
65. Ai3-15293
66. .beta.-antipyrine
67. Prestwick_26
68. Antipyrine Crystals
69. Mfcd00003146
70. Component Of Auralgan
71. 1,5-dimethyl-2-phenyl-pyrazol-3-one
72. Spectrum_000058
73. Antipyrine [mi]
74. Prestwick0_000029
75. Prestwick1_000029
76. Prestwick2_000029
77. Prestwick3_000029
78. Spectrum2_000088
79. Spectrum3_000305
80. Spectrum4_000152
81. Spectrum5_000842
82. Antipyrine [vandf]
83. Antipyrinum [hpus]
84. Antipyrine (jp17/usp)
85. Epitope Id:124927
86. Phenazone [mart.]
87. Ec 200-486-6
88. Phenazone [who-dd]
89. 1,5-dimethyl-2-phenyl-1h-pyrazol-3(2h)-one
90. Antipyrine [usp-rs]
91. Schembl20452
92. Bspbio_000097
93. Bspbio_001870
94. Kbiogr_000624
95. Kbioss_000438
96. Mls001331753
97. Mls001332401
98. Mls001332402
99. Mls002154179
100. Divk1c_000484
101. Spectrum1500128
102. Spbio_000016
103. Spbio_002018
104. Antipyrine, Analytical Standard
105. Bpbio1_000107
106. Chembl277474
107. Phenazone [ep Impurity]
108. Dtxsid6021117
109. Phenazone [ep Monograph]
110. Hms501i06
111. Kbio1_000484
112. Kbio2_000438
113. Kbio2_003006
114. Kbio2_005574
115. Kbio3_001370
116. Zinc61044
117. Antipyrine [usp Impurity]
118. Nsc7945
119. Antipyrine, >=99.0% (rt)
120. Ninds_000484
121. Antipyrine [usp Monograph]
122. Hms1568e19
123. Hms1920e09
124. Hms2091k09
125. Hms2095e19
126. Hms2272g04
127. Hms3652c09
128. Hms3712e19
129. Hms3885c11
130. Pharmakon1600-01500128
131. Wln: T5nnvj A1 Br& E1
132. Hy-b0171
133. Tox21_110342
134. Tox21_201600
135. Tox21_303026
136. Antipyrine, Sigma Reference Standard
137. Bdbm50103600
138. Ccg-38904
139. Nsc755874
140. S3173
141. Stk328171
142. 1,5-dimethyl-2-phenyl-3-pyrazolone
143. Phenazone 100 Microg/ml In Methanol
144. Akos000588788
145. Tox21_110342_1
146. Cs-2044
147. Db01435
148. Nsc-755874
149. Idi1_000484
150. Phenazone 10 Microg/ml In Acetonitrile
151. Antipyrine, Analytical Reference Material
152. Antipyrine, Tested According To Ph.eur.
153. Ncgc00016274-01
154. Ncgc00016274-02
155. Ncgc00016274-03
156. Ncgc00016274-05
157. Ncgc00016274-06
158. Ncgc00016274-07
159. Ncgc00016274-09
160. Ncgc00016274-10
161. Ncgc00094591-01
162. Ncgc00094591-02
163. Ncgc00094591-03
164. Ncgc00178937-01
165. Ncgc00178937-02
166. Ncgc00256527-01
167. Ncgc00259149-01
168. As-13248
169. Sbi-0051287.p003
170. Antipyrine, Vetec(tm) Reagent Grade, 98%
171. D1876
172. Ft-0609690
173. Ft-0662246
174. Sw196343-3
175. A19580
176. Bim-0051287.0001
177. D01776
178. H11233
179. Propyphenazone Impurity A [ep Impurity]
180. 1,5-dimethyl-2-phenyl-1,2-dihydropyrazol-3-one
181. A936893
182. Af-960/00437050
183. Q415578
184. Q-201552
185. Sr-05000001566-1
186. Sr-05000001566-3
187. Brd-k46937689-001-05-1
188. Brd-k46937689-001-08-5
189. Z56869297
190. 2-trideuteromethyl-3-methyl-1-phenyl-3-pyrazolin-5-one
191. F2173-0728
192. 1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one #
193. Phenazone, European Pharmacopoeia (ep) Reference Standard
194. Antipyrine, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 188.23 g/mol |
|---|---|
| Molecular Formula | C11H12N2O |
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 188.094963011 g/mol |
| Monoisotopic Mass | 188.094963011 g/mol |
| Topological Polar Surface Area | 23.6 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 267 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antipyrine is an analgesic often used to test effects of other drugs on liver enzymes. In combination with benzocaine in otic solutions, antipyrine is indicated for the symptomatic relief of acute otitis media arising from various etiologies.
Antipyrine is an analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
N - Nervous system
N02 - Analgesics
N02B - Other analgesics and antipyretics
N02BB - Pyrazolones
N02BB01 - Phenazone
S - Sensory organs
S02 - Otologicals
S02D - Other otologicals
S02DA - Analgesics and anesthetics
S02DA03 - Phenazone
Antipyrine has known human metabolites that include 3-hydroxy-methylantipyrine, 4-hydroxy-antipyrine, and Norantipyrine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Antipyrine is thought to act primarily in the CNS, increasing the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin (PG) synthesis.
API SUPPLIERS
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4836
Submission : 1983-03-04
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5940
Submission : 1985-07-25
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : R1-CEP 2001-042 - Rev 01
Issue Date : 2008-05-16
Type : Chemical
Substance Number : 421
Status : Withdrawn by EDQM F...
Date of Issue : 2019-12-06
Valid Till : 2022-09-16
Written Confirmation Number : WC-0188A1
Address of the Firm :
Certificate Number : R1-CEP 2002-093 - Rev 03
Issue Date : 2017-07-20
Type : Chemical
Substance Number : 421
Status : Valid
NDC Package Code : 58624-0620
Start Marketing Date : 2008-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Topical
Coating Systems & Additives
Film Formers & Plasticizers
Co-Processed Excipients
Thickeners and Stabilizers
Controlled & Modified Release
Granulation
Direct Compression
Taste Masking
Solubilizers
Fillers, Diluents & Binders
Emulsifying Agents
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Antipyrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antipyrine, including repackagers and relabelers. The FDA regulates Antipyrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antipyrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antipyrine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antipyrine supplier is an individual or a company that provides Antipyrine active pharmaceutical ingredient (API) or Antipyrine finished formulations upon request. The Antipyrine suppliers may include Antipyrine API manufacturers, exporters, distributors and traders.
click here to find a list of Antipyrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antipyrine DMF (Drug Master File) is a document detailing the whole manufacturing process of Antipyrine active pharmaceutical ingredient (API) in detail. Different forms of Antipyrine DMFs exist exist since differing nations have different regulations, such as Antipyrine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antipyrine DMF submitted to regulatory agencies in the US is known as a USDMF. Antipyrine USDMF includes data on Antipyrine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antipyrine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antipyrine suppliers with USDMF on PharmaCompass.
A Antipyrine CEP of the European Pharmacopoeia monograph is often referred to as a Antipyrine Certificate of Suitability (COS). The purpose of a Antipyrine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Antipyrine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Antipyrine to their clients by showing that a Antipyrine CEP has been issued for it. The manufacturer submits a Antipyrine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Antipyrine CEP holder for the record. Additionally, the data presented in the Antipyrine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Antipyrine DMF.
A Antipyrine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Antipyrine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Antipyrine suppliers with CEP (COS) on PharmaCompass.
A Antipyrine written confirmation (Antipyrine WC) is an official document issued by a regulatory agency to a Antipyrine manufacturer, verifying that the manufacturing facility of a Antipyrine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Antipyrine APIs or Antipyrine finished pharmaceutical products to another nation, regulatory agencies frequently require a Antipyrine WC (written confirmation) as part of the regulatory process.
click here to find a list of Antipyrine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antipyrine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antipyrine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antipyrine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antipyrine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antipyrine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antipyrine suppliers with NDC on PharmaCompass.
Antipyrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antipyrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antipyrine GMP manufacturer or Antipyrine GMP API supplier for your needs.
A Antipyrine CoA (Certificate of Analysis) is a formal document that attests to Antipyrine's compliance with Antipyrine specifications and serves as a tool for batch-level quality control.
Antipyrine CoA mostly includes findings from lab analyses of a specific batch. For each Antipyrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antipyrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Antipyrine EP), Antipyrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antipyrine USP).
LOOKING FOR A SUPPLIER?
